Spark Plus

https://lnkd.in/gdC399hX Spark Plus hosted its Australian Equities Day during the Singapore Formula 1 Grand Prix. We brought our ASX listed clients to meet with our investor network in Singapore. Conference, Yacht and F1 tickets a recipe for successful networking. Thank you for our sponsors and media partners Simon Allsop, Lel Smits GAICD Filip Karinja Bryce Green Lara Paholski Cordell Smith Shaun Cartwright Julia Maguire Very proud of all of our presenters as well, really apprecaite your support as clients. Iggy Tan, Bruce Lane, Tim Fung, Mike Pivac, Gavin Ball, Michael Baker, Gary Phillips, Michael Thurn, Glenn Cross, Brian Leedman, Anton Uvarov PhD MBA, John Rayment GAICD, Jayne Shaw, Dave Darling, Martin Stein Tony Davies Jonathan Chi Patrick Grove Alex Longman Peter Christie Knar Loveday Our team is very proud for putting such an event together to highlight small cap companies on the ASX. Please reach out to us if you are keen to roadshow into Asia (Singapore, Hong Kong, Thailand). Omar Taheri Nathan Hauritz Timothy Wong Stefan Tan, CFA Andréa C. Jack Zhang Pathhik Vora Brett Walker

Spenda (ASX:SPX) Capricorn Initiatives Update – DSD and SwiftStatement now commercial MD: Adrian Floate Non-Executive Chairman: Peter Richards spenda.co

The Calmer Co. (ASX : CCO) Sales surpass $10m annualised revenue in October CEO: Zane Yoshida fijikava.com

Lithium Universe (ASX:LU7) Completes Share Placement and Launches Entitlement Offer Joint Lead Managers: Spark Plus & Ignite Equity Co-Manager: GBA Capital Executive Chairman: Iggy Tan lithiumuniverse.com

Brett Walker who is running the Perth office for Spark Plus was out at the South-West Connect ASX Showcase this week. Great conference as usual Stewart McDonald. See you in Singapore in 2025.

Join us for an exclusive Investor Roadshow Evening with Recce Pharmaceuticals Ltd (ASX: RCE) hosted by Spark Plus on the 24th of October 2024 in beautiful Phuket, Thailand. This is a unique opportunity to network and hear directly from CEO James Graham about Recce’s cutting-edge advancements in the field of anti-infectives. We're thrilled to be expanding our investor network into Thailand, continuing to spearhead corporate access for Australian companies in Asia. 📍 Location: Drinks & Co Phuket 🗓 Date: 24th October 2024 ⏰ Time: 5:30 p.m. onwards Secure your spot and RSVP today! Don’t miss out on this chance to connect with like-minded investors and explore new opportunities. 💼✨ #ReccePharmaceuticals #InvestorNetworking #SparkPlus #PhuketEvent #ThailandInvestors #AntiInfectives #PharmaInnovation #InvestorRoadshow

Arovella Therapeutics ASX: ALA - Clinical Advisory Board (CAB) Established in Preparation for FDA IND Application ◦ The CAB will provide expert clinical insight and strategic advice focusing on CD19-positive haematological malignancies (blood cancers), as the Company looks to file its IND and commence its first-in-human phase 1 clinical trial. ◦ Each member has been carefully selected, due to their experience working with cell therapies in early-stage clinical trials. CEO & MD: Michael Baker www.arovella.com

ActivePort Group Ltd (ASX:ATV) Renounceable Rights Issue to Raise up to $5.3 Million Highlights: • 3 for 4 Renounceable Rights Issue to raise up to $5.3 million • Attractively priced at 2 cents per share • Discount of 50% to the September 30-day VWAP • With every 3 New Shares, shareholders receive 1 free attaching New Option • New Options will have Exercise Price of 10 cents, term of 3 years • Shareholders can trade their rights and apply for additional shares and options • Rights to start trading from December 2024 • Funds to be used to strengthen the balance sheet and for working capital to accelerate growth. Chairman: Peter Christie www.activeport.com.au

Power Minerals Limited (ASX:PNN) POWER ADVANCING TO FULLY FUNDED JV & 100% OFF TAKE AT PULAR LITHIUM PROJECT Highlights – Power Minerals and lithium extraction technology provider Heng Li Technology (HengLi) have successfully completed due diligence for the proposed joint venture for the funding and development of the Pular Lithium Project – The parties now plan to execute a formal Transaction Agreement by entering into a binding Joint Venture to fund and develop Pular into a lithium-producing operation – Under the proposed Transaction Agreement, HengLi will fully fund and manage development of the Project with funding to be provided at the project level, avoiding Power shareholder dilution – HengLi also proposes to purchase 100% of the lithium concentrate produced at the Pular Project – HengLi’s technology uses a combination of direct lithium extraction (DLE) and evaporation and can deliver cost, water and energy savings compared to DLE and evaporation methods used separately – Power has funding and development agreements in place for the Incahuasi, Rincon and Pular Projects, providing a commercialisation pathway for the Salta Project’score assets Mena Habib www.powerminerals.com.au

The Calmer Co. (ASX : CCO) Acquisition of Navua Facility and Freehold land. • The company has executed a binding offer to purchase the current manufacturing site in which it operates now, which KAP has accepted. • The agreed purchase price for the land, buildings and all built-in plant is 4.4m FJD. • The freehold land parcel is 5,856m2 encompassing the facility and several residential dwellings, which will be used as staff quarters. • The internal floorspace of the facility totals 1,930m2, including office space, a laboratory, two cold rooms, a blast freezer and mezzanine level storage. • KAP’s kava processing activities will continue on the site for the next 1 year, under a tenancy agreement. • The offer was made subject to finance. CEO: Anthony Noble www.thecalmerco.com